Project Number 5R21AG068833-02 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for D1 dopamine receptor positive allosteric modulators as a practical treatment for cognitive decline Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator FRANKOWSKI, KEVIN J Principal Investigator First Name KEVIN J Principal Investigator Last Name FRANKOWSKI Awardee Organization UNIV OF NORTH CAROLINA CHAPEL HILL Awardee State North Carolina Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-19-146: Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed) FY Overall Cost $233,250 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
